ARTICLE SUMMARY:
FDA device authorizations jumped to a five-year high, and more stats and facts on fiscal year 2026 FDA device activities.
All categories of FDA novel device authorizations tracked by Market Pathways grew in FY 2026. Meanwhile, the agency published 32 device-related guidance documents during the period, about the same as last year, while foreign inspection numbers continued to decline.